The elevated level of circulating insulin, typical for obesity phenotype, was found to increase the intestinal permeability, allowing bacterial toxins, such as LPS, to leak into the circulation, which, in turn, initiated a cascade of inflammatory reactions, thus, explaining the subclinical inflammation present in obese and insulin-resistant patients [48]. Here, INS is linked to obesity disorder.